Search

Contributor:

and Will To, OD, ABOC

Four Eyes

Four Eyes

COVID-19: Are Today's Protocols Tomorrow's Routines?

The Art of Drug Choice: International Panel in Wet AMD: Phase 3 and Real-World Data to Watch

COVID-19: Key Technologies

Fluid in Neovascular Age-Related Macular Degeneration – Evolution of Understanding

COVID-19: Are Today's Protocols Tomorrow's Routines?

John Kitchens, MD; Murtaza "Moo" Adam, MD; David R.P. Almeida, MD, PhD, MBA; and Christina Weng, MD, MBA

COVID-19: Key Technologies

John Kitchens, MD; Caroline Baumal, MD; María Berrocal, MD; and Judy Kim, MD

Back to Practice: COVID-19 Clinical and Surgical Protocols: Which Changes Are Here to Stay?

International Perspectives: How Will Artificial Intelligence Affect the Practice of Ophthalmology?

Back to Practice: Telemedicine in the COVID-19 Era

Back to Practice: Technology and COVID-19: Necessity Is the Mother of Invention

Back to Practice: Education as In-Person Meetings Are Paused

COVID-19: International Perspectives

COVID-19 Updates From Europe

Angiogenesis 2021: Wet AMD

Clinical Impacts From AAO 2020: Drs. Singh, Ehlers, and Gillies

jCell Therapy for Retinitis Pigmentosa and Phase 2B Data

Clinical Impacts From AAO 2020: Drs. Singh, Do, and Heier

Coding Changes for 2021 at AAO

The Art of Drug Choice: International Panel in Wet AMD: Safety Data

AAO Late Breaker: Ang-2 Mediation in DME Therapy